Vulvovaginal carriage of yeasts other than Candida albicans

被引:67
作者
Holland, J
Young, ML
Lee, O
Chen, SCA
机构
[1] Mayne Hlth Laverty Pathol, N Ryde, NSW 2113, Australia
[2] Westmead Hosp, ICPMR, Sydney, NSW, Australia
关键词
D O I
10.1136/sti.79.3.249
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Aims: We investigated the spectrum of yeasts isolated, and compared the epidemiological and laboratory characteristics of women carrying vulvovaginal Candida albicans with those carrying yeasts other than C albicans. Method: Between April and June 2001, 5802 consecutively received genital swabs from women were plated onto Candida ID chromogenic media (BioMerieux). Blue colonies were reported as C albicans; all other colonies (white and pink) were identified to species level using the Vitek YBC card (BioMerieux). In vitro susceptibility to amphotericin (AMB), fluconazole (FLU), itraconazole (ITZ), and voriconazole (VOR) was determined for approximately 40% of non-C albicans yeasts using a standardised microdilution method. Results: Yeast was isolated from 1221 women (21%). Of these, C albicans only was isolated from 1087 (89%) and yeasts other than C albicans from 129 (11%) women. C glabrata comprised 89 (69%) of the latter. Women in whom other yeasts were recovered were older than those with C albicans (mean 43, versus 33 years, p <0.001). All isolates tested (n=53) were susceptible to AMB and VOR. Seven (24%) C glabrata strains were susceptible to FLU with 21 (72%) testing susceptible-dose dependent. Conclusion: Yeasts other than C albicans are common vaginal isolates even in a primary care population. The species isolated are less susceptible to FLU than most C albicans.
引用
收藏
页码:249 / 250
页数:2
相关论文
共 12 条
[1]   Outcome in critically ill patients with candidal fungaemia:: Candida albicans vs. Candida glabrata [J].
Blot, S ;
Vandewoude, K ;
Hoste, E ;
Poelaert, J ;
Colardyn, F .
JOURNAL OF HOSPITAL INFECTION, 2001, 47 (04) :308-313
[2]   In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature [J].
Espinel-Ingroff, A ;
Boyle, K ;
Sheehan, DJ .
MYCOPATHOLOGIA, 2001, 150 (03) :101-115
[3]   Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans [J].
Fidel, PL ;
Vazquez, JA ;
Sobel, JD .
CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :80-+
[4]   Evaluation of candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species [J].
Fricker-Hidalgo, H ;
Orenga, S ;
Lebeau, B ;
Pelloux, H ;
Brenier-Pinchart, MP ;
Ambroise-Thomas, P ;
Grillot, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1647-1649
[5]   Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation [J].
Kronvall, G ;
Karlsson, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1422-1428
[6]  
*NAT COMM CLIN LAB, M27A NAT COMM CLIN L
[7]  
ODDS FC, 1988, ECOLOGY CANDIDA EPID, P85
[8]   Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections:: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 [J].
Pfaller, MA ;
Diekema, DJ ;
Jones, RN ;
Messer, SA ;
Hollis, RJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :852-856
[9]   Vaginitis due to Candida krusei:: Epidemiology, clinical aspects, and therapy [J].
Singh, S ;
Sobel, JD ;
Bhargava, P ;
Boikov, D ;
Vazquez, JA .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (09) :1066-1070
[10]   VAGINITIS DUE TO SACCHAROMYCES-CEREVISIAE - EPIDEMIOLOGY, CLINICAL ASPECTS, AND THERAPY [J].
SOBEL, JD ;
VAZQUEZ, J ;
LYNCH, M ;
MERIWETHER, C ;
ZERVOS, MJ .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (01) :93-99